To solve this problem, we need to identify which technique does not serve the purpose of early diagnosis of a disease for its early treatment. Let's analyze each option:$\newline \bullet$Recombinant DNA Technology:$\newline$ - This technology involves manipulating DNA to create new genetic combinations.$\newline$ - It is primarily used for genetic engineering, gene therapy, and the production of genetically modified organisms.$\newline$ - While it has applications in developing diagnostic tools, it is not directly used for early diagnosis.$\newline \bullet$Serum and Urine analysis:$\newline$ - These analyses are common diagnostic tests used to detect various diseases and conditions.$\newline$ - They help in the early diagnosis of diseases by identifying biomarkers or abnormal levels of substances.$\newline$ - Therefore, they serve the purpose of early diagnosis.$\newline \bullet$Polymerase Chain Reaction (PCR) technique:$\newline$ - PCR is a technique used to amplify small segments of DNA.$\newline$ - It is widely used in the early diagnosis of infectious diseases, genetic disorders, and cancer.$\newline$ - Thus, it serves the purpose of early diagnosis.$\newline \bullet$Enzyme Linked Immuno-Sorbent Assay (ELISA) technique:$\newline$ - ELISA is a test that uses antibodies and color change to identify a substance.$\newline$ - It is commonly used for the early diagnosis of diseases by detecting antigens or antibodies.$\newline$ - Therefore, it serves the purpose of early diagnosis.$\newline$Based on the analysis, the technique that does not primarily serve the purpose of early diagnosis is:$\newline$Option 1: Recombinant DNA Technology.$\newline$However, the correct option provided is Option 2: Serum and Urine analysis.$\newline$This seems to be an error, as serum and urine analysis are indeed used for early diagnosis.$\newline$Therefore, the correct answer should be Option 1: Recombinant DNA Technology.